Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2002
07/04/2002WO2001038510A3 Integration vectors and method for producing recombinant proteins in fungi
07/04/2002WO2001037643A9 Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes
07/04/2002WO2001035811A9 Methods of diagnosing and determining prognosis of breast cancer
07/04/2002WO2001034808A3 Method of large-scale production and method of testing of the biological activity of a substance from soybean
07/04/2002WO2001034806A9 Methods and compositions for screening using diphtheria toxin constructs
07/04/2002WO2001030813A9 Novel molecules of the card-related protein family and uses thereof
07/04/2002WO2001030374A9 Stem cell engraftment-enhancing cellular proteins and their uses
07/04/2002WO2000073316A3 Virus immunologic determinants
07/04/2002WO2000071565A9 Fluorescent protein indicators
07/04/2002WO2000069909A9 Isolation and characterization of epidermal growth factor related protein
07/04/2002WO2000069900A9 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
07/04/2002WO2000069897A9 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
07/04/2002WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
07/04/2002WO2000068242A9 Collagen-binding proteins from enterococcal bacteria
07/04/2002WO2000024871A3 Kv BETA 1.1-DEFICIENT MICE WITH IMPAIRED LEARNING
07/04/2002WO2000022430A9 Neisseria genomic sequences and methods of their use
07/04/2002US20020088029 Genetically engineering plant cells; obtain cell, incubate with agrobacterium, heat, recover and propagate transformed plant
07/04/2002US20020088028 Identification and characterization of a DWARF AND LATE FLOWERING 2 phenotype ( DLF2) in arabidopsis
07/04/2002US20020088027 Expression of biologically active polypeptides in duckweed
07/04/2002US20020088025 Expressing preferential protein in cells; obtain cell, transform with expression vector containing preferential polypeptides, propagate cells, recover polypeptides
07/04/2002US20020088024 Nucleotide sequences coding enzymatic protein for use in the treatment of lysosomal storage defects
07/04/2002US20020088022 Nucleotide sequences coding preferential protein for use in the generation of disease resistant plants
07/04/2002US20020088021 Mucleotide sequences coding polypeptide for use in detection of nucleotide sequence mutation
07/04/2002US20020088018 Transgenic mice containing MAS orphan receptor gene disruptions
07/04/2002US20020088015 Wilms' tumor wt1 binding proteins
07/04/2002US20020088014 Minimal adenovirus mediated recombinant vaccine
07/04/2002US20020088012 Nucleotide sequences for use in the prevention of microorganismal infections
07/04/2002US20020086988 Polypeptide for use as tools in human therapeutics and diagnostics
07/04/2002US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders
07/04/2002US20020086986 Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
07/04/2002US20020086984 Nucleotide sequences coding preferential polypeptides for use in the detection, prevention and treatment of microorganismal infection
07/04/2002US20020086983 Protein for use in the treatment Alzheimer's, Parkinson's and cancer
07/04/2002US20020086982 Novel EBI-3-ALT protein and nucleic acid molecules and uses therefor
07/04/2002US20020086981 Method of isolation of regulated virulence determinants from bacterial pathogens
07/04/2002US20020086980 Nucleotide sequences coding a polypeptide for use in the treatment of apoptosis defects
07/04/2002US20020086979 Reagents and methods useful for detecting diseases of the breast
07/04/2002US20020086978 Specific binding agents
07/04/2002US20020086976 Peptide for use in the treatment of autoimmune disease
07/04/2002US20020086975 P2u2 receptor antibodies
07/04/2002US20020086973 Folding protein into wild type configuration; obtain culture, adjust ionic concentration, incubate with folding catalyst, centrifuge broth, oxidize supernatant, recover polypeptide
07/04/2002US20020086972 Adaptor protein FRS2 and related products and methods
07/04/2002US20020086848 Associated with Fanconi anaemia (FA), a genetic disease; antibodies, gene therapy
07/04/2002US20020086845 Rat PTTG polypeptide and method for producing it
07/04/2002US20020086844 Methods and reagents to regulate apoptosis
07/04/2002US20020086843 Derived from human brain and possessing natriuretic activity; treating edema, hypertension, congestive heat failure, and acute and chronic renal failure
07/04/2002US20020086839 Inhibitors of DNA immunostimulatory sequence activity
07/04/2002US20020086836 Cftr gene regulator
07/04/2002US20020086831 Methods and use of motoneuronotrophic factors
07/04/2002US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC
07/04/2002US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
07/04/2002US20020086826 Antibodies against ligand for receptor activator of NF-kB
07/04/2002US20020086825 Genes associated with mechanical stress, expression products therefrom, and uses thereof
07/04/2002US20020086823 Nucleic acids, proteins, and antibodies
07/04/2002US20020086822 Nucleic acids, proteins, and antibodies
07/04/2002US20020086821 Nucleic acids, proteins, and antibodies
07/04/2002US20020086820 Respiratory system related polynucleotides and polypeptides (antigens) for detection/diagnosis of cancer
07/04/2002US20020086819 Conjugating polymer (polyethylene glycol) to biologically active molecule (polypeptide); human urokinase plasminogen activator
07/04/2002US20020086817 Mannan-binding protein or gene; vaccinia virus vectors
07/04/2002US20020086813 Mutants of streptococcal toxin a and methods of use
07/04/2002US20020086812 Gene expression inhibition; for treatment of cancer of pancreas, lungs, prostates, livers, ovaries, cervices, and/or breasts; drug delivery
07/04/2002US20020086444 Isolated menbrane protein for use in the diagnosis and treatment of alzheimer's disease
07/04/2002US20020086427 Inducible eukaryotic expression system that regulates protein translation
07/04/2002US20020086426 Controlling gene expression; obtain cell, transform with expression vector, transcribe and monitor generation of tetracycline
07/04/2002US20020086421 Tumor cells with increased immunogenicity and uses therefor
07/04/2002US20020086420 Novel antiangiogenic peptides
07/04/2002US20020086419 Episomal vector and uses thereof
07/04/2002US20020086414 Novel ctla4/cd28 ligands and uses therefor
07/04/2002US20020086413 LktA deletion mutant of P. haemolytica
07/04/2002US20020086412 Generating preferential bacteria; obtain genetically engineered bacteria sample, inoculate nutrient broth, propagate, express genes, recover heterologous products
07/04/2002US20020086409 Methods and compounds for modulating male fertility
07/04/2002US20020086404 Nucleotide sequences coding for the luxR gene
07/04/2002US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer
07/04/2002US20020086401 Nucleotide sequences coding transport protein; for use generating antiproliferative agents
07/04/2002US20020086396 Human transcription factor IIA
07/04/2002US20020086392 Checkpoint-activating oligonucleotides
07/04/2002US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides
07/04/2002US20020086384 Nucleotide sequences coding transcription regulatory sequence for use in the diagnosis, prevention and treatment of cancer
07/04/2002US20020086383 Cell expansion factor; for use in the treatment and prevention of graft rejection
07/04/2002US20020086382 Nucleotide sequences coding membrane protein for use in the prevention and treatment of autoimmune diseases
07/04/2002US20020086379 Human membrane-spanning proteins
07/04/2002US20020086374 Polynucleotide coding transport protein for use in generation of preferential amino acids
07/04/2002US20020086372 Nucleotide sequences coding enzymatic polypeptide for use in generating lysine; for use in animal feeds, human medicine and pharmacology
07/04/2002US20020086371 Microorganism for use in the generation of lysine; for use in the generation of enzymatic polypeptides for animal feeds and nutrients
07/04/2002US20020086368 Human toll homologues
07/04/2002US20020086367 Novel secreted proteins
07/04/2002US20020086366 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator
07/04/2002US20020086365 Nucleotide sequencs which code polypeptide for use in the treatment of psychological and neurological disorders
07/04/2002US20020086364 Protein for use in the treatment and prevention of cancer, autoimmune, respiratory, bone and nervous system disorders, inflammation, Crohn's disease and bacterial infections; wound healing agents
07/04/2002US20020086363 G-protein parathyroid hormone receptor HLTDG74
07/04/2002US20020086362 Human amine receptor
07/04/2002US20020086361 Polypeptide for use in detecting cancer and treating osteoporosis
07/04/2002US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke
07/04/2002US20020086359 Polypeptide for use in controlling signal transduction
07/04/2002US20020086357 32591, a novel human GTPase activating molecule and uses therefor
07/04/2002US20020086354 Nucleotide sequences coding preferential polypeptide for use in the treatment and prevention of cell proliferative disorders
07/04/2002US20020086352 Methods for expressing endostatin protein
07/04/2002US20020086351 Human nodal and lefty homologues
07/04/2002US20020086350 Microbial swollenin protein, dna sequences encoding such swollenins and method of producing such swollenins
07/04/2002US20020086349 Nucleic acid molecules which code proteins which mediate the adhesion of neisseria cells to human cells
07/04/2002US20020086348 Tolerogenic fragments of natural allergens